Aurobindo Pharma Shares Fall After USFDA Flags Severe Contamination, Data Integrity Failures
The USFDA further highlighted deficiencies in environmental monitoring in manufacturing areas, indicating gaps in ensuring controlled production conditions.
The USFDA further highlighted deficiencies in environmental monitoring in manufacturing areas, indicating gaps in ensuring controlled production conditions.
What's Your Reaction?
